Home > National Drug Code (NDC) > Transderm Scop

Transderm Scop - 10019-553-02 - (Scopalamine)

Alphabetical Index


Drug Information of Transderm Scop

Product NDC: 10019-553
Proprietary Name: Transderm Scop
Non Proprietary Name: Scopalamine
Active Ingredient(s): 1    mg/3d & nbsp;   Scopalamine
Administration Route(s): TRANSDERMAL
Dosage Form(s): PATCH, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Transderm Scop

Product NDC: 10019-553
Labeler Name: Baxter Healthcare Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA017874
Marketing Category: NDA
Start Marketing Date: 20030101

Package Information of Transderm Scop

Package NDC: 10019-553-02
Package Description: 24 POUCH in 1 BOX (10019-553-02) > 1 PATCH in 1 POUCH > 3 d in 1 PATCH

NDC Information of Transderm Scop

NDC Code 10019-553-02
Proprietary Name Transderm Scop
Package Description 24 POUCH in 1 BOX (10019-553-02) > 1 PATCH in 1 POUCH > 3 d in 1 PATCH
Product NDC 10019-553
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Scopalamine
Dosage Form Name PATCH, EXTENDED RELEASE
Route Name TRANSDERMAL
Start Marketing Date 20030101
Marketing Category Name NDA
Labeler Name Baxter Healthcare Corporation
Substance Name SCOPOLAMINE
Strength Number 1
Strength Unit mg/3d
Pharmaceutical Classes Anticholinergic [EPC],Cholinergic Antagonists [MoA]

Complete Information of Transderm Scop


General Information